Oncology; primary focus of visit; surveillance for disease recurrence for patient who has completed definitive cancer-directed therapy and currently lacks evidence of recurrent disease; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project)
This is the 2010 version of HCPCS G9052 - please refer to the 2016 HCPCS code set for the latest version.
Added on Sunday, January 01, 2006
Status changed on Monday, January 01, 2007 to: No maintenance for this code
BETOS Classification: Oncology > Other
Medicare coverage status: Not payable by Medicare (no grace period)
